ROSE HIU: Open Payments
NPI 1538255914 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 12 payments from 7 companies in 2025. Trend: 2023 $436 · 2024 $408 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 5 | $138 |
| BeiGene USA, Inc. | 2 | $64 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| ABBVIE INC. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $14 |
Products named: BRUKINSA, BLENREP, EPKINLY, Vyloy, TAVALISSE, Venclexta.
Industry payments across CA — which companies pay providers there.
